Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test if interleukin-2, a drug that stimulates the immune
system, can be used after chemotherapy to slow the progression of your disease. We also want
to test what the best dose of interleukin-2 is that can be used safely at home.
Interleukin-2, abbreviated as IL2, is a naturally produced growth hormone for the immune
cells in our body. It stimulates the growth of the immune cells and enhances their ability to
fight infections and cancers. In people with cancer, the immune cells are typically
suppressed and became even more so after irradiation and chemotherapy treatment. By giving
you more IL2 we hope to enhance the immune system so that it can fight the cancer better,
control cancer growth and shrink the cancer.